Skip to main content

SpiderRock Advisors, LLC

SEC CIK
0001703301
Latest filing
Nov 1, 2024

DSGN holding history

Design Therapeutics, Inc. in every 13F filed by SpiderRock Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DSGN overviewAll 13F holders of DSGNFull Q3 2024 holdings

Shares (Q3 2024)
26,965
Value
$145.1K
% of portfolio
<0.1%
Quarters held
1
Since Q3 2024
Holdings of DSGN by SpiderRock Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202426,965$145.1K<0.1%+26,965NewHolders